Evidence map›Paper›PMID 40347322›Full record

ArticleApoptosis : an international journal on programmed cell death2025

Correction to: Elevated serum mtDNA in COVID‑19 patients is linked to SARS‑CoV‑2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release.

Anna Shteinfer-Kuzmine, Ankit Verma, Rut Bornshten, Eli Ben Chetrit, Ami Ben-Ya'acov, Hadas Pahima, Ethan Rubin, Yosef Mograbi, Eyal Shteyer, Varda Shoshan-Barmatz

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Anna Shteinfer-Kuzmine *National Institute for Biotechnology in the Negev, Beer‑Sheva, Israel.
Ankit Verma *National Institute for Biotechnology in the Negev, Beer‑Sheva, Israel.
Rut BornshtenThe Shraga Segal Dept. of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer‑Sheva, 84105, Israel.
Eli Ben ChetritInfectious Diseases Unit, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel.
Ami Ben-Ya'acovShaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology, Jerusalem, Israel.
Hadas PahimaDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer‑Sheva, 84105, Israel.
Ethan RubinThe Shraga Segal Dept. of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer‑Sheva, 84105, Israel.
Yosef Mograbi, Tel Aviv‑Yafo, Israel.
Eyal ShteyerNational Institute for Biotechnology in the Negev, Beer‑Sheva, Israel.
Varda Shoshan-BarmatzNational Institute for Biotechnology in the Negev, Beer‑Sheva, Israel. vardasb@bgu.ac.il.ORCID http://orcid.org/0000-0002-6756-4340

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40347322
PMCPMC12167304

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.